{
  "cik": 1984086,
  "cik_padded": "0001984086",
  "entityName": "Septerna, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-098507",
      "filed": "2026-03-09",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 518000.0,
        "cash": 120722000.0,
        "eps_diluted": -1.1,
        "free_cash_flow": 109671000.0,
        "net_income": -48879000.0,
        "operating_cash_flow": 110189000.0,
        "operating_income": -68297000.0,
        "revenue": 45951000.0,
        "stockholders_equity": 381926000.0,
        "total_assets": 596187000.0,
        "total_liabilities": 214261000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.5610013458104449,
        "net_margin": -1.0637200496180714,
        "operating_margin": -1.4863006245783552,
        "revenue_growth_yoy": 41.74511627906977,
        "roa_avg2y": -0.09286044715651808,
        "roa_period_end": -0.0819860211645004,
        "roe_avg2y": -0.12189687183982503,
        "roe_period_end": -0.12798028937542874
      }
    },
    {
      "accn": "0001193125-26-098507",
      "filed": "2026-03-09",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2103000.0,
        "cash": 238196000.0,
        "eps_diluted": -7.26,
        "free_cash_flow": -69573000.0,
        "net_income": -71798000.0,
        "operating_cash_flow": -67470000.0,
        "operating_income": -80823000.0,
        "revenue": 1075000.0,
        "stockholders_equity": 420047000.0,
        "total_assets": 456554000.0,
        "total_liabilities": 36507000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.08691170273802694,
        "roa_avg2y": -0.2444515943420477,
        "roa_period_end": -0.1572606964345948,
        "roe_avg2y": -0.3762278180536742,
        "roe_period_end": -0.1709284913354934
      }
    },
    {
      "accn": "0001193125-26-098507",
      "filed": "2026-03-09",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2878000.0,
        "cash": 88483000.0,
        "eps_diluted": 0.29,
        "free_cash_flow": -41601000.0,
        "net_income": 4180000.0,
        "operating_cash_flow": -38723000.0,
        "operating_income": 2075000.0,
        "stockholders_equity": -38374000.0,
        "total_assets": 130867000.0,
        "total_liabilities": 20026000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": 0.03194082541817265,
        "roe_avg2y": -0.10124129579170452
      }
    },
    {
      "accn": "0000950170-25-045745",
      "filed": "2025-03-27",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -44201000.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-098507",
    "filed": "2026-03-09",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001984086.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001984086.json"
  },
  "ticker": "SEPN"
}